Headlands Technologies’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Buy |
+11,886
| New | +$653K | 0.08% | 261 |
|
|
2025
Q1 | – | Sell |
-1,787
| Closed | -$117K | – | 1160 |
|
|
2024
Q4 | $117K | Buy |
+1,787
| New | +$117K | 0.01% | 636 |
|
|
2024
Q2 | – | Sell |
-5,692
| Closed | -$497K | – | 1172 |
|
|
2024
Q1 | $497K | Buy |
5,692
+4,411
| +344% | +$385K | 0.12% | 192 |
|
|
2023
Q4 | $124K | Buy |
1,281
+1,159
| +950% | +$112K | 0.04% | 352 |
|
|
2023
Q3 | $10.8K | Sell |
122
-1,857
| -94% | -$164K | 0.01% | 686 |
|
|
2023
Q2 | $172K | Buy |
+1,979
| New | +$172K | 0.05% | 310 |
|